Furthermore, genomic sequencing of 71 paediatric and adult osteosarcoma samples reported 20% had an amplification at 4q12 spanning PDGFRA, VEGFR2, and KIT, and in total, 40% of participants had either PDGFRA or VEGF amplification [166]. This evidence concerns the gene KDR and osteosarcoma.